Vanguard Personalized Indexing Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$5.26 Billion
Q2 2024

A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 9,559 shares of REGN stock, worth $9.96 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

9,559

Previous 8,430 13.39%

Holding current value

$9.96 Million

Previous $8.11 Million 23.83%

% of portfolio

0.19%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $997,132 - $1.21 Million	1,129 Added 13.39%	9,559 $10 Million
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $348,438 - $383,433	386 Added 4.8%	8,430 $8.11 Million
Q4 2023 Feb 07, 2024	BUY	$775.18 - $881.7 $58,138 - $66,127	75 Added 0.94%	8,044 $7.06 Million
Q3 2023 Nov 08, 2023	BUY	$692.45 - $844.37 $560,884 - $683,939	810 Added 11.31%	7,969 $6.56 Million
Q2 2023 Jul 28, 2023	BUY	$700.03 - $830.35 $177,107 - $210,078	253 Added 3.66%	7,159 $5.14 Million
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $381,074 - $463,103	560 Added 8.82%	6,906 $5.67 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $107,295 - $116,491	152 Added 2.45%	6,346 $4.58 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $554,455 - $699,693	966 Added 18.48%	6,194 $4.27 Million
Q2 2022 Aug 09, 2022	BUY	$548.35 - $738.84 $702,436 - $946,454	1,281 Added 32.46%	5,228 $3.09 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $693,909 - $814,369	1,166 Added 41.93%	3,947 $2.76 Million
Q4 2021 Feb 23, 2022	BUY	$543.48 - $670.97 $239,674 - $295,897	441 Added 18.85%	2,781 $1.76 Million
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $264,627 - $313,922	461 Added 24.53%	2,340 $1.42 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $315,357 - $372,546	667 Added 55.03%	1,879 $1.05 Million
Q1 2021 Apr 28, 2021	BUY	$446.73 - $548.2 $7,147 - $8,771	16 Added 1.34%	1,212 $573,000
Q4 2020 Jan 20, 2021	BUY	$478.3 - $607.98 $572,046 - $727,144	1,196 New	1,196 $578,000
Q4 2020 Jan 19, 2021	SELL	$478.3 - $607.98 $595,005 - $756,327	-1,244 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$544.75 - $658.21 $78,444 - $94,782	144 Added 13.09%	1,244 $696,000
Q2 2020 Jul 27, 2020	BUY	$493.32 - $643.92 $29,105 - $37,991	59 Added 5.67%	1,100 $686,000
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $349,963 - $514,701	1,041 New	1,041 $508,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account

Vanguard Personalized Indexing Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History